Regulation of cell growth by selective COX-2 inhibitors in oral carcinoma cell lines

C Y Yang1, C L Meng, C L Liao

  • 1Department of Dentistry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.

Insights

Selective cyclooxygenase-2 (COX-2) inhibitors significantly inhibited oral cancer cell growth, suggesting COX-2 plays a role in oral cancer progression. Non-steroidal anti-inflammatory drugs targeting COX-2 show potential for oral cancer treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Non-steroidal anti-inflammatory drugs (NSAIDs) inhibiting prostaglandin synthesis are linked to reduced colorectal cancer incidence.
  • Cyclooxygenase-2 (COX-2) inhibition is a proposed mechanism for NSAID-mediated cancer chemoprevention.

Purpose of the Study:

  • To investigate the role of COX-2 in oral cancer by examining the effects of selective COX-2 inhibitors on oral carcinoma cell lines.
  • To compare the efficacy of selective COX-2 inhibitors (Celebrex, DFU, NS-398) versus a COX-1 inhibitor (Aspirin) on oral cancer cell growth.

Main Methods:

  • Treatment of human oral carcinoma cell lines (OEC-M1, KB) and a normal fibroblast cell line (NF) with varying concentrations of selective COX-2 inhibitors and COX-1 inhibitors.
  • Assessment of cell growth inhibition over different time periods (2-6 days).
  • Determination of half-maximal inhibitory concentration (IC50) values for the inhibitors on the cell lines.

Main Results:

  • Selective COX-2 inhibitors (DFU, Celebrex, NS-398) significantly inhibited the growth of both OEC-M1 and KB oral cancer cell lines.
  • The COX-1 inhibitor Aspirin did not show significant growth inhibition.
  • NS-398 demonstrated the lowest IC50 values, indicating potent inhibition of oral cancer cell growth.

Conclusions:

  • COX-2 selective inhibitors effectively suppress the growth of human oral carcinoma cell lines.
  • These findings support the hypothesis that COX-2 is involved in the proliferation of oral cancer cells.
  • Targeting COX-2 may represent a viable therapeutic strategy for human oral cancer.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Cell Cycle Control System02:11

The Cell Cycle Control System

The cell cycle is an organized set of events that leads the cell to divide into two daughter cells, each containing chromosomes identical to the parent cell. It is the cell cycle that leads to the formation of an entire organism from a single-cell zygote. Besides, cell division also functions in the renewal or repair of tissues in adult multicellular eukaryotes. For example, in the bone marrow, the stem cells divide to form new blood cells. Although essential for several functions, cell...